Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Adv Skin Wound Care. 2024 Jan 1;37(1):26–31. doi: 10.1097/ASW.0000000000000082

Table 2:

Short-Term Outcomes Following STSG

Outcome Treatment

(n=446)
Control

(n=446)
p-value Odds

Ratio
Odds CI
Death 10 2.20% 10 2.20% 1 1 (0.412,2.426)
Graft Failure 12 2.64% 10 2.20% 0.666 1.21 (0.515,2.819)
Re-grafting 18 3.97% 11 2.42% 0.1865 1.663 (0.776,3.561)
Infection 52 11.45% 84 18.50% 0.0029* 0.57 (0.392,0.828)
Hematoma 19 4.19% 18 3.97% 0.8667 1.058 (0.548,2.043

Short-term was defined as being within the first month following STSG.